Health Condition 1: null- Breast Cancer and Gynaecology Cancer
Conditions
Interventions
None listed
Sponsors
Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: Patients with breast or gynaecologic cancer undergoing systemic chemotherapy under Department of Medical Oncology, Tata Memorial Centre will be eligible for recruitment. 2. Histologically confirmed invasive/metastatic carcinoma of the breast or gynaecologic malignancy. 3. ECOG /PS 0-2 at study entry 4. Age 18 to 65 years 5. Patient willing to participate and sign ICF
Exclusion criteria
Exclusion criteria: 1. Not consenting for participation or not willing to fill-up the study questionnaire 2. Patients undergoing an investigational therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify adverse effects and distressing symptoms of breast and gynaecologic patients undergoing systemic therapy and analysing their effects on the patient, by recording them using a Patient Reported Outcomes (PROs) questionnaire, specially designed and tested for validity and reliability in an initial pilot study. Incidence of symptoms: Pain, Vomiting, Diarrhoea, Constipation, Tingling/Numbness, Appetite loss, Fatigue, Hot flushes, Soreness of mouth, other.Timepoint: To identify adverse effects and distressing symptoms of breast and gynaecologic patients undergoing systemic therapy and analysing their effects on the patient, by recording them using a Patient Reported Outcomes (PROs) questionnaire, specially designed and tested for validity and reliability in an initial pilot study. Incidence of symptoms: Pain, Vomiting, Diarrhoea, Constipation, Tingling/Numbness, Appetite loss, Fatigue, Hot flushes, Soreness of mouth, other. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactMr Yogesh Kembhavi
Tata Memorial Centre
Outcome results
None listed